Dr. Jonathan Stine is an Associate Professor of Medicine and Public Health Sciences at Penn State where he serves as the Fatty Liver Program Director and Liver Center Research Director.

As an internationally recognized liver expert with a research and clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD), he has authored more than 115 peer-reviewed papers, including multinational consensus guidelines for the American College of Sports Medicine and Exercise and Sports Science Australia, and has lectured across the United States and Europe.

Dr. Stine has been the recipient of multiple research grants and awards from the American Association for the Study of Liver Diseases, American Cancer Society and National Institutes of Health.

His research has been featured by various media outlets including ABC, the Associated Press, Yahoo and STAT News. Since 2023, he has been recognized by Stanford University as being among the World’s Top 2% Scientists.

Dr. Jonathan G. Stine is a transplant hepatologist and internationally recognized expert in liver disease with a primary clinical focus on metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

As Program Director of the Penn State Health Fatty Liver Program and Research Director for the Penn State Health Liver Center, his clinical practice integrates advanced diagnostics, multidisciplinary treatment, and evidence-based care to improve outcomes for patients with MASLD, MASH, and liver transplantation needs.

Dr. Stine is passionate about leveraging exercise and lifestyle interventions as foundational therapies for patients with metabolic liver disease, helping bridge the gap between emerging research and clinical application.

With decades of experience as a thought leader in hepatology, Dr. Stine’s work is informed by participation in over 30 MASLD/MASH clinical trials and development of multinational consensus guidelines. His approach to care is both compassionate and innovative, focusing on empowering patients through personalized treatment strategies that target the root causes of liver disease. By combining his clinical expertise with a commitment to improving patient quality of life, Dr. Stine continues to set new standards for managing metabolic liver disorders.

Fellow of the American College of Physicians (FACP), 2016

Member, American Association for the Study of Liver Diseases

Member, American College of Gastroenterology

Member, American College of Sports Medicine

Member, European Association for the Study of the Liver

Member, International Liver Transplantation Society